Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Corticotropin releasing factor receptor antagonists

Corticotropin releasing factor receptor antagonists

US Patent 11311549 · Granted Apr 26, 2022

Estimated economic value: $1,376,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
Corticotropin releasing factor receptor antagonists2024
Corticotropin releasing factor receptor antagonists2024
Corticotropin releasing factor receptor antagonists2024
Methods for the treatment of abnormal involuntary movement disorders2024
Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cel2023
Methods for the treatment of abnormal involuntary movement disorders2023
Methods for the treatment of abnormal involuntary movement disorders2023
Methods for the treatment of abnormal involuntary movement disorders2022
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2022
Methods for the treatment of abnormal involuntary movement disorders2022
Corticotropin releasing factor receptor antagonists2022